Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Adobe Acrobat has largely catered to professionals with its recent AI features. Now, the company is turning its attention to students by making Acrobat more useful with the launch of a new AI tool ...

Old growth forest in the Tongass National Forest, the planet’s largest intact temperate rainforest. The Tongass currently contains contains 9.2 million roadless acres, but the Trump administration's ...

I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...

AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.

We've tested the top AI image generation apps to help you find the one that produces the best results for the lowest price. I’ve been writing about consumer technology and video games for more than a ...

When you export cookies from your main browser, you are extracting all cookies from your entire browsing session — including banking sessions, email authentication tokens, private account credentials, ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

AI drug discovery specialist Generate Biomedicines has raised $400 million in the year’s largest initial public offering to date for a biotechnology firm. The company, which was launched in 2018 by ...

Latvian startup Deep Space Energy SIA announced Wednesday it has raised €930,000, about $1.1 million, in pre-seed funding to advance novel radioscopic generator technology for the European space and ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...